title: Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study".
authors.affiliation: Department of Haematology, SA Pathology, Adelaide, South Australia, Australia; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia; The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia. Electronic address: amy.hughes@sahmri.com.
authors.forename: Amy
authors.initials: A
authors.lastname: Hughes
authors.affiliation: Department of Haematology, SA Pathology, Adelaide, South Australia, Australia; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
authors.forename: Jade
authors.initials: J
authors.lastname: Clarson
authors.affiliation: Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology and The University of South Australia, Adelaide, South Australia, Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
authors.forename: Tessa
authors.initials: T
authors.lastname: Gargett
authors.affiliation: Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology and The University of South Australia, Adelaide, South Australia, Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
authors.forename: Wenbo
authors.initials: W
authors.lastname: Yu
authors.affiliation: The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia; Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology and The University of South Australia, Adelaide, South Australia, Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Brown
authors.affiliation: Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia.
authors.forename: Angel F
authors.initials: AF
authors.lastname: Lopez
authors.affiliation: Department of Haematology, SA Pathology, Adelaide, South Australia, Australia; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia; The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia.
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Hughes
authors.affiliation: Department of Haematology, SA Pathology, Adelaide, South Australia, Australia; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia; The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia.
authors.forename: Agnes S M
authors.initials: AS
authors.lastname: Yong
mesh_terms: D000911:Antibodies, Monoclonal; D019337:Hematologic Neoplasms; D006801:Humans; D020794:Receptor Protein-Tyrosine Kinases; D036121:Receptor, EphA3
chemical_list: D000911:Antibodies, Monoclonal; C000621320:KB004; C491718:EPHA3 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D036121:Receptor, EphA3